Skip to Main Content

Paper Details

<i>BRAF</i> Mutations Occur Infrequently in Ovarian Cancer but Suggest Responsiveness to BRAF and MEK Inhibition.
JCO Precis Oncol
7
2018
BRAF, MEK, Ovarian Cancer
Author NameAffiliation
Victor E VelculescuSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine
Dennis J SlamonDavid Geffen School of Medicine, University of California los angeles
Gottfried E KonecnyDavid Geffen School of Medicine, University of California los angeles
  • 1 - 3

Datasets

Release 1.2